Talk:Apricitabine

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

AIDS Mid‑importance

	This article is part of WikiProject AIDS, an attempt to build a comprehensive, detailed, and accessible guide to AIDS, HIV, and related topics on Wikipedia. If you would like to participate in the project, you can choose to edit this article, or visit the project page for more information.AIDSWikipedia:WikiProject AIDSTemplate:WikiProject AIDSAIDS articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Apricitabine.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

A fact from Apricitabine appeared on Wikipedia's Main Page in the Did you know column on 8 September 2008 (check views). The text of the entry was as follows:

Did you know... that the new antiretroviral drug apricitabine was invented at a Canadian drug manufacturer, which was bought by the British company Shire plc, who sold the drug's development rights to an Australian company?

A record of the entry may be seen at Wikipedia:Recent additions/2008/September.

Wikipedia

This article was nominated for deletion on 29 August 2008. The result of the discussion was keep.